Related Experiment Video
Updated: Jul 19, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Postnatal inflammatory rat model for cerebral palsy: too different from humans
Robin Roberson1, Jade E Woodard, Laura Toso
1Unit on Perinatal and Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
American Journal of Obstetrics and Gynecology
|September 27, 2006
Summary
Neonatal lipopolysaccharide (LPS) exposure caused brain white matter damage and accelerated neurodevelopment in rodents. This study suggests targeting preoligodendrocytes (Pre-OL) may not replicate a cerebral palsy (CP) phenotype in this model.
Area of Science:
- Neuroscience
- Developmental Biology
- Immunology
Background:
- Cerebral palsy (CP) may stem from inflammation affecting vulnerable preoligodendrocytes (Pre-OL) during critical gestational periods.
- This study investigates a postnatal CP model to understand injury related to Pre-OL presence in developing brains.
Purpose of the Study:
- To evaluate the impact of neonatal lipopolysaccharide (LPS) exposure on white matter development and neurobehavioral outcomes.
- To determine if this postnatal inflammatory insult in rodents leads to a CP-like phenotype by affecting Pre-OL.
Main Methods:
- Neonatal rat pups were administered lipopolysaccharide (LPS) or saline on postnatal days 2-6.
- Motor and cognitive development were assessed in neonates and adult offspring using tests like negative geotaxis, surface righting, rotarod, and beam walking.
- White matter damage was evaluated by analyzing preoligodendrocyte (Pre-OL) markers (CNP, PLP) via immunohistochemistry.
Main Results:
- LPS-treated pups showed accelerated performance in negative geotaxis and surface righting tests.
- Adult LPS-exposed offspring exhibited enhanced motor control in rotarod and beam walking tasks.
- Altered levels of Pre-OL markers (CNP, PLP) were observed in LPS-treated animals at both P22 and 12 weeks, indicating white matter changes.
Conclusions:
- Neonatal LPS exposure induced white matter damage and accelerated neurodevelopment and motor function in adult rodents.
- The observed outcomes, including accelerated neurodevelopment, differ from typical CP phenotypes.
- These findings suggest that targeting preoligodendrocytes (Pre-OL) in this specific postnatal rodent model does not replicate the human cerebral palsy (CP) condition.
